| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |